APA

Adiwijaya B. S., Kim J., Lang I., Csõszi T., Cubillo A., Chen J., Wong M., Park J. O., Kim J. S., Rau K. M., Melichar B., Gallego J. B., Fitzgerald J., Belanger B., Molnar I. & Ma W. W. (20171222). Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. : Clinical pharmacology and therapeutics.

Chicago

Adiwijaya B S, Kim J, Lang I, Csõszi T, Cubillo A, Chen J-S, Wong M, Park J O, Kim J S, Rau K M, Melichar B, Gallego J B, Fitzgerald J, Belanger B, Molnar I and Ma W W. 20171222. Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. : Clinical pharmacology and therapeutics.

Harvard

Adiwijaya B. S., Kim J., Lang I., Csõszi T., Cubillo A., Chen J., Wong M., Park J. O., Kim J. S., Rau K. M., Melichar B., Gallego J. B., Fitzgerald J., Belanger B., Molnar I. and Ma W. W. (20171222). Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. : Clinical pharmacology and therapeutics.

MLA

Adiwijaya B S, Kim J, Lang I, Csõszi T, Cubillo A, Chen J-S, Wong M, Park J O, Kim J S, Rau K M, Melichar B, Gallego J B, Fitzgerald J, Belanger B, Molnar I and Ma W W. Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. : Clinical pharmacology and therapeutics. 20171222.